Literature DB >> 1388450

Decapitation ischemia-induced release of free fatty acids in mouse brain. Relationship with diacylglycerols and lysophospholipids.

G Y Sun1, F L Lu, S E Lin, M R Ko.   

Abstract

In this study, the release of lysophospholipids (to depict phospholipase A2 activity) and diacylglycerols (DG) (to depict stimulated hydrolysis of polyphosphoinositides) was related to the decapitation-induced release of free fatty acid (FFA) in the mouse brain. To assay for lysophospholipids, Balb/c mice were injected intracerebrally with either [3H]choline or [3H]inositol for 16 h in order to label their respective phospholipids. These lipids were examined at various times (30 s to 30.5 min) after decapitation. Between 30 s and 1.5 min after decapitation, the rate of FFA release (3 micrograms FA/mg FA in phospholipids/min) was three times more rapid than that between 10 and 15 min (0.8 microgram FA/mg FA in phospholipids/min). FFA released during the initial phase were enriched in 20:4 and 18:0 whereas those released during the latter phase were nonspecific. The DG fatty acids are enriched in 18:0 and 20:4. Ischemia induced a rapid release of DG as measured by its fatty acid content (3.2 micrograms FA/mg FA in phospholipids/min). Unlike FFA, the level of DG reached a plateau after 1.5 min and remained elevated for the entire 30.5 min. In agreement with previous notions indicating the involvement of phospholipase A2 in ischemic insult, steady increases in radioactivity of both lysophosphatidylcholines and lysophosphatidylinositols were observed with time after decapitation. Based on the preferential increase in both 18:0 and 20:4 during the initial time period, the results suggest that poly-PI hydrolysis coupled to DG-lipase may contribute to the initial release of FFA, whereas the FFA released subsequent to the initial phase may be mainly a result of activation of phospholipase A2 acting on phosphatidylcholines and phosphatidylinositols.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1388450     DOI: 10.1007/bf03159980

Source DB:  PubMed          Journal:  Mol Chem Neuropathol        ISSN: 1044-7393


  10 in total

1.  In situ metabolite and lipid analysis of GluN2D-/- and wild-type mice after ischemic stroke using MALDI MSI.

Authors:  William T Andrews; Deborah Donahue; Adam Holmes; Rashna Balsara; Francis J Castellino; Amanda B Hummon
Journal:  Anal Bioanal Chem       Date:  2020-02-28       Impact factor: 4.142

2.  N-Acylphosphatidylethanolamine accumulation in potato cells upon energy shortage caused by anoxia or respiratory inhibitors.

Authors:  A J Rawyler; R A Braendle
Journal:  Plant Physiol       Date:  2001-09       Impact factor: 8.340

3.  Relation between free fatty acid and acyl-CoA concentrations in rat brain following decapitation.

Authors:  J Deutsch; S I Rapoport; A D Purdon
Journal:  Neurochem Res       Date:  1997-07       Impact factor: 3.996

4.  Regulation of FFA by the acyltransferase pathway in focal cerebral ischemia-reperfusion.

Authors:  J P Zhang; G Y Sun
Journal:  Neurochem Res       Date:  1995-11       Impact factor: 3.996

5.  Matrix effects in biological mass spectrometry imaging: identification and compensation.

Authors:  Ingela Lanekoff; Susan L Stevens; Mary P Stenzel-Poore; Julia Laskin
Journal:  Analyst       Date:  2014-07-21       Impact factor: 4.616

6.  Lysophosphatidic acid receptor activation affects the C13NJ microglia cell line proteome leading to alterations in glycolysis, motility, and cytoskeletal architecture.

Authors:  Eva Bernhart; Manfred Kollroser; Gerald Rechberger; Helga Reicher; Akos Heinemann; Petra Schratl; Seth Hallström; Andrea Wintersperger; Christoph Nusshold; Trevor DeVaney; Klaus Zorn-Pauly; Roland Malli; Wolfgang Graier; Ernst Malle; Wolfgang Sattler
Journal:  Proteomics       Date:  2010-01       Impact factor: 3.984

7.  Formation of eicosanoids, E2/D2 isoprostanes, and docosanoids following decapitation-induced ischemia, measured in high-energy-microwaved rat brain.

Authors:  Santiago E Farias; Mireille Basselin; Lisa Chang; Kim A Heidenreich; Stanley I Rapoport; Robert C Murphy
Journal:  J Lipid Res       Date:  2008-05-23       Impact factor: 5.922

Review 8.  Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies.

Authors:  Luiz Henrique Medeiros Geraldo; Tânia Cristina Leite de Sampaio Spohr; Rackele Ferreira do Amaral; Anna Carolina Carvalho da Fonseca; Celina Garcia; Fabio de Almeida Mendes; Catarina Freitas; Marcos Fabio dosSantos; Flavia Regina Souza Lima
Journal:  Signal Transduct Target Ther       Date:  2021-02-01

Review 9.  Neuropsychiatric Manifestations of Antiphospholipid Syndrome-A Narrative Review.

Authors:  Yik Long Man; Giovanni Sanna
Journal:  Brain Sci       Date:  2022-01-11

10.  1-Oleyl-lysophosphatidic acid (LPA) promotes polarization of BV-2 and primary murine microglia towards an M1-like phenotype.

Authors:  Ioanna Plastira; Eva Bernhart; Madeleine Goeritzer; Helga Reicher; Vishwanath Bhat Kumble; Nora Kogelnik; Andrea Wintersperger; Astrid Hammer; Stefanie Schlager; Katharina Jandl; Akos Heinemann; Dagmar Kratky; Ernst Malle; Wolfgang Sattler
Journal:  J Neuroinflammation       Date:  2016-08-26       Impact factor: 9.587

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.